Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors

被引:55
作者
Berque-Bestel, I [1 ]
Soulier, JL [1 ]
Giner, M [1 ]
Rivail, L [1 ]
Langlois, M [1 ]
Sicsic, S [1 ]
机构
[1] Fac Pharm Chatenay Malabry, Biocis, UMR C8076, CNRS, F-92296 Chatenay Malabry, France
关键词
D O I
10.1021/jm0307887
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Fluorescent antagonists for human 5-HT4 receptors were synthesized based on ML10302 1, a potent 5-HT4 receptor agonist and on piperazine analogue 2. These molecules were derived with three fluorescent moieties, dansyl, naphthalimide, and NBD (7-nitrobenz-2-oxa-1,3-diazol-4-yl), through alkyl chains. The synthesized molecules were evaluated in binding assays on the recently cloned human 5-HT4(e) receptor isoform stably expressed in C6 glial cells with [H-3]GR113808 as the radioligand. The affinity values depended upon the basal structure together with the alkyl chain length. The derivatives based on ML10302 were more potent ligands than the derivatives based on piperazine analogue. For ML10302-based ligands, dansyl and NBD derivatives attached through a chain length of one carbon atom 17a and 32, respectively, led to affinities close to the affinity of ML10302. The most potent compounds 17a, 28, and 32 produced an inhibition of the 5-HT stimulated cyclic AMP synthesis in the same cellular system with nanomolar K-b values. Fluorescent properties of 17a, 28, and 32 were more particularly studied. Interactions of the fluorescent ligand 28 with the h5-HT4(e) receptor were indicated using h5-HT4(e) receptor transfected C6 glial cell membranes and entire cells. Ligand 28 was also used in fluorescence microscopy experiments in order to label h5-HT4(e) receptor transfected C6 glial cells, and subcellular localization of these receptors was more precisely determined using confocal microscopy.
引用
收藏
页码:2606 / 2620
页数:15
相关论文
共 44 条
[1]   Synthesis of a novel fluorescent probe for estrogen receptor [J].
Adamczyk, M ;
Reddy, RE ;
Yu, ZG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (09) :1283-1285
[2]  
AHMED FAM, 1990, SYNLETT, V9, P537
[3]   THE UV-VISIBLE ABSORPTION AND FLUORESCENCE OF SOME SUBSTITUTED 1,8-NAPHTHALIMIDES AND NAPHTHALIC ANHYDRIDES [J].
ALEXIOU, MS ;
TYCHOPOULOS, V ;
GHORBANIAN, S ;
TYMAN, JHP ;
BROWN, RG ;
BRITTAIN, PI .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1990, (05) :837-842
[4]   SELECTIVE FLUORESCENT LIGANDS FOR PHARMACOLOGICAL RECEPTORS [J].
BAINDUR, N ;
TRIGGLE, DJ .
DRUG DEVELOPMENT RESEARCH, 1994, 33 (04) :373-398
[5]   CONCEPTS AND PROGRESS IN THE DEVELOPMENT AND UTILIZATION OF RECEPTOR-SPECIFIC FLUORESCENT LIGANDS [J].
BAINDUR, N ;
TRIGGLE, DJ .
MEDICINAL RESEARCH REVIEWS, 1994, 14 (06) :591-664
[6]   Fluorescent ligands for studying neuropeptide receptors by confocal microscopy [J].
Beaudet, A ;
Nouel, D ;
Stroh, T ;
Vandenbulcke, F ;
Dal-Farra, C ;
Vincent, JP .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1998, 31 (11) :1479-1489
[7]  
Blondel O, 1998, J NEUROCHEM, V70, P2252
[8]   SYNTHESIS AND DETERMINATION OF THE CHIRALITY SENSE OF (+)-(R)-1-AZABICYCLO[3.3.1]NONAN-2-ONE [J].
BREHM, R ;
OHNHAUSER, D ;
GERLACH, H .
HELVETICA CHIMICA ACTA, 1987, 70 (08) :1981-1987
[9]   Design, synthesis, and structure-activity relationship studies of novel 1-[(1-Acyl-4-piperidyl)methyl]-1H-2-methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists [J].
Carceller, E ;
Merlos, M ;
Giral, M ;
Balsa, D ;
GarciaRafanell, J ;
Forn, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) :487-493
[10]  
CLAYSEN S, 1998, MOL PHARMACOL, V34, P880